New Search

Export article

Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome

, Pieter Sonneveld, Jesús F. San Miguel, Heather J. Sutherland, , Arnon Nagler, Andrew Spencer, Tadeusz Robak, Keith C. Lantz, Sen H. Zhuang,
Show More
Published: 1 February 2011
Clinical Lymphoma Myeloma and Leukemia , Volume 11, pp 44-49; doi:10.3816/clml.2011.n.005

The publisher has not yet granted permission to display this abstract.
Keywords: safety / multiple myeloma / Efficacy / doxorubicin / PEGylated / plus Bortezomib / PLD plus / outcomes over bortezomib

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

Share this article

Click here to see the statistics on "Clinical Lymphoma Myeloma and Leukemia" .
References (17)
    Cited by 25 articles
      Back to Top Top